https://thefrancejournal.com/article/914590251-china-leading-in-stock-dram-chip-distributor-vs-industry-competitors-e-best-advantages The France Journal en PressRelease 2026-05-23T12:14:50+00:00 China Leading In-Stock DRAM Chip Distributor vs Industry Competitors: E-BEST Advantages https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24865254-dram-chip-distributor1-1216x1028.jpeg https://thefrancejournal.com/article/914592586-what-makes-e-best-a-reliable-wholesaler-for-in-stock-hard-to-find-electronic-components-in-global-markets The France Journal en PressRelease 2026-05-23T12:02:59+00:00 What Makes E-BEST a Reliable Wholesaler for In-Stock Hard-to-Find Electronic Components in Global Markets? https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24865275-reliable-wholesaler-for-in-stoc-1867x1082.jpeg https://thefrancejournal.com/article/914096550-sweet-briar-college-farm-releases-meritage-125-in-honor-of-125th-anniversary The France Journal en PressRelease 2026-05-23T12:00:00+00:00 Sweet Briar College Farm Releases Meritage 125 in Honor of 125th Anniversary https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24863832-meritage-125-debuts-in-honor-of-2398x1600.jpeg https://thefrancejournal.com/article/914339833-from-future-of-ai-to-geopolitics-wmf-presents-the-training-program-with-90-stages-and-1-000-international-speakers The France Journal en PressRelease 2026-05-22T12:51:16+00:00 From future of AI to geopolitics: WMF presents the training program with +90 stages and 1.000 international speakers https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24864596-wmf-training-program-2048x1367.jpeg https://thefrancejournal.com/article/914318521-cancer-vaccines-market-to-witness-massive-growth-by-2033-neovax-bio-celluvax-inc The France Journal en PressRelease 2026-05-22T11:41:51+00:00 Cancer Vaccines Market to Witness Massive Growth by 2033 | NeoVax Bio, CelluVax Inc. https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24864507-cancer-vaccines-market-1024x1024.jpeg https://thefrancejournal.com/article/914311280-ceo-of-leading-quantum-hardware-company-alice-bob-responds-to-president-macron-s-strengthened-plan-quantique The France Journal en PressRelease 2026-05-22T11:30:00+00:00 CEO of Leading Quantum Hardware Company Alice & Bob Responds to President Macron’s Strengthened Plan Quantique https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24828607-alice-bob-logo-04-2026-624x207.png https://thefrancejournal.com/article/914301913-keolis-mhi-celebrates-international-day-of-families-with-special-work-family-balance-wellbeing-webinar The France Journal en PressRelease 2026-05-22T09:58:07+00:00 Keolis MHI Celebrates International Day of Families with Special 'Work-Family Balance' Wellbeing Webinar https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24864438-work-family-balance-wellbeing-600x400.jpeg https://thefrancejournal.com/article/914296783-breakfirst-games-releases-demo-for-chaotic-couch-co-op-game-sheep-socks The France Journal en PressRelease 2026-05-22T09:41:19+00:00 Breakfirst Games Releases Demo for Chaotic Couch Co-op Game Sheep & Socks https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24864418-s-s-press-1-1170x473.jpeg https://thefrancejournal.com/article/914437253-nanobiotix-announces-full-exercise-of-underwriters-over-allotment-option-bringing-gross-proceeds-of-offering-to-approximately-100-million The France Journal en PressRelease 2026-05-22T20:15:00+00:00 NANOBIOTIX Announces Full Exercise of Underwriters’ Over-Allotment Option, Bringing Gross Proceeds of Offering to Approximately $100 Million https://ml.globenewswire.com/media/36fb7b98-27d7-46cb-b989-fa31626657b8/small/nanobiotix-logo-jpg.jpg https://thefrancejournal.com/article/914437258-nanobiotix-annonce-l-exercice-integral-de-l-option-de-surallocation-portant-le-produit-de-l-offre-a-100-millions-de-dollars The France Journal en PressRelease 2026-05-22T20:15:00+00:00 NANOBIOTIX annonce l’exercice integral de l’option de surallocation, portant le produit de l'offre a 100 millions de dollars https://ml.globenewswire.com/media/36fb7b98-27d7-46cb-b989-fa31626657b8/small/nanobiotix-logo-jpg.jpg https://thefrancejournal.com/article/914437169-abivax-presents-first-quarter-2026-financial-results-and-reports-three-year-interim-data-from-study-108-a-phase-2a-2b-open-label-extension-trial-of The France Journal en PressRelease 2026-05-22T20:05:00+00:00 Abivax Presents First Quarter 2026 Financial Results and Reports Three-Year Interim Data from Study 108, a Phase 2a/2b Open-Label Extension Trial of Obefazimod Following Dose De-Escalation in Patients with Ulcerative Colitis https://ml-eu.globenewswire.com/media/5470cd7e-c1fe-402f-8673-925c82bbd2fb/small/abivax-logo-rgb-png.png https://thefrancejournal.com/article/914437171-abivax-pr-sente-ses-r-sultats-financiers-du-t1-2026-et-les-donn-es-trois-ans-de-l-tude-108-un-essai-d-extension-ouvert-de-phase-2a-2b-valuant The France Journal en PressRelease 2026-05-22T20:05:00+00:00 Abivax présente ses résultats financiers du T1 2026 et les données à trois ans de l’étude 108, un essai d’extension ouvert de phase 2a/2b évaluant l’obéfazimod après réduction de dose dans la RCH https://ml-eu.globenewswire.com/media/5470cd7e-c1fe-402f-8673-925c82bbd2fb/small/ https://thefrancejournal.com/article/913986139-le-compositeur-espagnol-jordi-forni-s-pr-sente-ra-z-y-recuerdo-m-moire-des-racines The France Journal en PressRelease 2026-05-22T06:00:00+00:00 Le compositeur espagnol Jordi Forniés présente Raíz y Recuerdo, Mémoire des racines https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24861723-jordi-forni-s-photo-piano-1-2048x1367.jpeg https://thefrancejournal.com/article/914015188-xs-com-renforce-sa-pr-sence-en-am-rique-latine-avec-un-nouveau-sponsoring-mondial-au-wealth-expo-colombie The France Journal en PressRelease 2026-05-22T05:13:38+00:00 XS.com renforce sa présence en Amérique latine avec un nouveau sponsoring mondial au Wealth Expo Colombie https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24863210-22-05-2026-en-wealth-expo-500x500.jpeg https://thefrancejournal.com/article/914133273-alice-bob-announces-series-b-extension The France Journal en PressRelease 2026-05-22T05:00:00+00:00 Alice & Bob announces Series B Extension https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24828607-alice-bob-logo-04-2026-624x207.png https://thefrancejournal.com/article/914383800-transgene-s-combined-general-meeting-of-may-22-2026 The France Journal en PressRelease 2026-05-22T15:45:00+00:00 Transgene’s Combined General Meeting of May 22, 2026 https://ml-eu.globenewswire.com/media/a1e966ec-4255-431c-b28a-c40c9e1f8733/small/transgene-logo-rvb2026-png.png https://thefrancejournal.com/article/914383804-assembl-e-g-n-rale-mixte-de-transgene-du-22-mai-2026 The France Journal en PressRelease 2026-05-22T15:45:00+00:00 Assemblée Générale Mixte de Transgene du 22 mai 2026 https://ml-eu.globenewswire.com/media/2a0cee23-0b14-48ff-8db2-e5e966dd7bb5/small/transgene-logo-rvb2026-png.png https://thefrancejournal.com/article/914131234-kfsh-calls-for-scaling-ai-from-pilots-to-patient-impact-at-world-economic-forum-health-roundtable The France Journal en PressRelease 2026-05-21T21:12:57+00:00 KFSH Calls for Scaling AI from Pilots to Patient Impact at World Economic Forum Health Roundtable https://thefrancejournal.com/article/914263947-exel-industries-half-year-2025-2026-results The France Journal en PressRelease 2026-05-22T06:06:00+00:00 EXEL Industries: Half-year 2025–2026 results https://ml-eu.globenewswire.com/media/4e718614-9f06-4606-8441-e92f5c79ab74/small/logo-exel-png.png https://thefrancejournal.com/article/914263961-exel-industries-r-sultats-semestriels-2025-2026 The France Journal en PressRelease 2026-05-22T06:06:00+00:00 EXEL Industries : Résultats semestriels 2025–2026 https://ml-eu.globenewswire.com/media/4e718614-9f06-4606-8441-e92f5c79ab74/small/ https://thefrancejournal.com/article/914263955-ose-immunotherapeutics-annonce-les-r-sultats-de-topline-positifs-de-l-tude-de-phase-2-tedova-de-tedopi-dans-le-cancer-de-l-ovaire-en-rechute The France Journal en PressRelease 2026-05-22T05:30:00+00:00 OSE Immunotherapeutics annonce les résultats de Topline positifs de l'étude de Phase 2 TEDOVA de Tedopi® dans le cancer de l’ovaire en rechute https://ml-eu.globenewswire.com/media/e79ae2c6-fc13-4a02-9759-4ecc9c4fdb22/small/ https://thefrancejournal.com/article/914263967-ose-immunotherapeutics-reports-positive-topline-results-of-tedova-phase-2-trial-with-tedopi-in-recurrent-ovarian-cancer The France Journal en PressRelease 2026-05-22T05:30:00+00:00 OSE Immunotherapeutics Reports Positive Topline Results of TEDOVA Phase 2 Trial with Tedopi® in Recurrent Ovarian Cancer https://ml-eu.globenewswire.com/media/e79ae2c6-fc13-4a02-9759-4ecc9c4fdb22/small/ose-logo-horizontal-rvb-png.png https://thefrancejournal.com/article/914263980-bull-liefert-finnlands-neuen-nationalen-supercomputer-roihu The France Journal en PressRelease 2026-05-22T05:30:00+00:00 Bull liefert Finnlands neuen nationalen Supercomputer „Roihu“ https://ml-eu.globenewswire.com/media/MzMzNTE4ODQtYjgxOC00YzE5LWE4MTAtY2M4ZTZhNGMzNWMzLTEwMTEwNjktMjAyNi0wNS0yMi1kZQ==/tiny/BULL-SAS.png https://thefrancejournal.com/article/914263983-bull-delivers-roihu-finland-s-new-national-supercomputer The France Journal en PressRelease 2026-05-22T05:30:00+00:00 Bull delivers Roihu, Finland’s new national supercomputer https://ml-eu.globenewswire.com/media/MzMzNTE4ODQtYjgxOC00YzE5LWE4MTAtY2M4ZTZhNGMzNWMzLTEwMTEwNjktMjAyNi0wNS0yMi1lbg==/tiny/BULL-SAS.png https://thefrancejournal.com/article/914263979-vallourec-and-syngular-solutions-sign-a-memorandum-of-understanding-to-accelerate-the-development-of-bioenergy-with-carbon-capture-and-storage The France Journal en PressRelease 2026-05-22T05:00:00+00:00 VALLOUREC AND SYNGULAR SOLUTIONS SIGN A MEMORANDUM OF UNDERSTANDING TO ACCELERATE THE DEVELOPMENT OF BIOENERGY WITH CARBON CAPTURE AND STORAGE PROJECTS https://ml-eu.globenewswire.com/media/d0facaa4-8800-44b0-b9d5-4aebb94fa89a/small/logo-jpg.jpg https://thefrancejournal.com/article/914263987-vallourec-et-syngular-solutions-signent-un-protocole-d-accord-pour-acc-l-rer-le-d-veloppement-de-projets-de-bio-nergie-associes-a-la-capture-et-au The France Journal en PressRelease 2026-05-22T05:00:00+00:00 VALLOUREC ET SYNGULAR SOLUTIONS SIGNENT UN PROTOCOLE D’ACCORD POUR ACCÉLÉRER LE DÉVELOPPEMENT DE PROJETS DE BIOÉNERGIE ASSOCIES A LA CAPTURE ET AU STOCKAGE DU CARBONE https://ml-eu.globenewswire.com/media/d0facaa4-8800-44b0-b9d5-4aebb94fa89a/small/ https://thefrancejournal.com/article/914127350-inventiva-to-present-at-2026-jefferies-global-healthcare-conference The France Journal en PressRelease 2026-05-21T20:00:00+00:00 Inventiva to Present at 2026 Jefferies Global Healthcare Conference   https://ml-eu.globenewswire.com/media/d96e203b-8941-46c7-888a-508900ab9a8b/small/logo-iva-jpg.jpg https://thefrancejournal.com/article/914127354-inventiva-pr-sentera-lors-de-la-2026-jefferies-global-healthcare-conference The France Journal en PressRelease 2026-05-21T20:00:00+00:00 Inventiva présentera lors de la 2026 Jefferies Global Healthcare Conference https://ml-eu.globenewswire.com/media/d96e203b-8941-46c7-888a-508900ab9a8b/small/ https://thefrancejournal.com/article/914127557-oddifact-obtient-la-d-signation-m-dicament-orphelin-de-la-commission-europ-enne-pour-l-infliximab-dans-la-maladie-de-kawasaki The France Journal en PressRelease 2026-05-21T18:50:22+00:00 ODDIFACT obtient la désignation médicament orphelin de la Commission Européenne pour l’infliximab dans la maladie de Kawasaki https://ml-eu.globenewswire.com/media/e678baea-021e-47f5-9676-4ef415772a73/small/ https://thefrancejournal.com/article/914127755-oddifact-receives-european-commission-orphan-drug-designation-for-infliximab-in-kawasaki-disease The France Journal en PressRelease 2026-05-21T18:50:22+00:00 ODDIFACT Receives European Commission Orphan Drug Designation for Infliximab in Kawasaki Disease https://ml-eu.globenewswire.com/media/e678baea-021e-47f5-9676-4ef415772a73/small/logo-oddifact-png.png https://thefrancejournal.com/article/914093843-stellantis-presents-fastlane-2030-financial-framework-targets-at-investor-day-2026 The France Journal en PressRelease 2026-05-21T17:21:15+00:00 Stellantis Presents FaSTLAne 2030 Financial Framework & Targets at Investor Day 2026 https://ml-eu.globenewswire.com/media/c44b1e4d-3fdd-4335-ac5e-8e83f0c963cb/small/stellantis-logo-white-background-jpg.jpg https://thefrancejournal.com/article/914093724-the-european-medicines-agency-accepts-teva-s-marketing-authorization-application-for-olanzapine-long-acting-injectable-tev-749-for-the-treatment-of The France Journal en PressRelease 2026-05-21T16:30:00+00:00 The European Medicines Agency Accepts Teva’s Marketing Authorization Application for Olanzapine Long-Acting Injectable (TEV-‘749) for the Treatment of Schizophrenia in Adults https://ml-eu.globenewswire.com/media/c2001734-949b-4cc2-8021-b4b64eda1f13/small/teva-rgb-jpeg-jpg.jpg